Drug industry steps up for credentialing group

Share this article:
The National Commission for the Certification of CME Professionals' voluntary certification program will not be out until fall 2007. That has not kept AstraZeneca and Merck, as well as several medical education entities from becoming “charter donors.” To earn the credential, candidates will have to meet specific criteria based on evidence of professional performance,
experience and completion of self-assessment, according to information on NC-CME.org.

Judy Ribble, PhD, NC-CME president, said she hopes small donations help the group attract a large foundation grant.

Maureen Doyle-Scharff, director of professional alliances, Ross, said, credentialing “would be a very positive step in the right direction from an industry perspective,” as a way to help ensure proposal competency.

Some medical societies agree, as their CME staffs need an increasingly broad skill set to collaborate on maintenance of certification.

Not everyone fully endorses NC-CME, and questions linger, such as who will pay for the
credential and test questions, who should take the exam and what's an apt re-certification plan.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in News

Five things for Pharma Marketers to know: Friday, August 29

Five things for Pharma Marketers to know: Friday, ...

Takeda closes out a good-news, bad-news kind of week, AstraZeneca adds a new clinical trial for its experimental PD-1, and researchers link a funeral to the Ebola outbreak.

Amgen sends PCSK9 to FDA

Amgen sends PCSK9 to FDA

Evolocumab holds the FDA's first filed biologics license application for the class.

Consultants expect M&A tempo to continue

Consultants expect M&A tempo to continue

PwC anticipates that divestitures will fuel late-2014 deals, but notes that the noise around early deals and the financials don't fully match up.